Literature DB >> 35673972

Errate: Efficacy and Toxicity of Adjuvant Therapies for High-Risk Endometrial Cancer in Stage I-III: A Systematic Review and Network Meta-Analysis.

Mengyin Ao1,2, Ting Ding1,2, Dan Tang1,2, Mingrong Xi1,2.   

Abstract

Source of support: This study was supported by grants from the Key Research and Development projects of Sichuan Province (No.2020YFS0129) and the Natural Science Foundation of China (No.61875249). Reference: Mengyin Ao, Ting Ding, Dan Tang, Mingrong Xi: Efficacy and Toxicity of Adjuvant Therapies for High-Risk Endometrial Cancer in Stage I-III: A Systematic Review and Network Meta-Analysis. Med Sci Monit, 2020; 26: e925595. DOI: 10.12659/MSM.925595.

Entities:  

Mesh：

Year:  2022        PMID： 35673972      PMCID： PMC9190250          DOI： 10.12659/MSM.937457

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN： 1234-1010


Source of support: This study was supported by grants from the Key Research and Development projects of Sichuan Province (No.2020YFS0129) and the Natural Science Foundation of China (No.61875249).
  1 in total

1.  Efficacy and Toxicity of Adjuvant Therapies for High-Risk Endometrial Cancer in Stage I-III: A Systematic Review and Network Meta-Analysis.

Authors:  Mengyin Ao; Ting Ding; Dan Tang; Mingrong Xi
Journal:  Med Sci Monit       Date:  2020-09-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.